nodes	percent_of_prediction	percent_of_DWPC	metapath
Alendronate—PTPRE—IL6-mediated signaling events—GAB1—polycystic ovary syndrome	0.0348	0.124	CbGpPWpGaD
Alendronate—PTPRE—adipose tissue—polycystic ovary syndrome	0.0303	0.0472	CbGeAlD
Alendronate—PTPN4—uterus—polycystic ovary syndrome	0.0295	0.046	CbGeAlD
Alendronate—PTPN4—pituitary gland—polycystic ovary syndrome	0.0289	0.0451	CbGeAlD
Alendronate—PTPN4—adipose tissue—polycystic ovary syndrome	0.0288	0.0449	CbGeAlD
Alendronate—PTPRE—adrenal gland—polycystic ovary syndrome	0.0272	0.0424	CbGeAlD
Alendronate—PTPN4—adrenal gland—polycystic ovary syndrome	0.0258	0.0403	CbGeAlD
Alendronate—PTPRE—female gonad—polycystic ovary syndrome	0.0253	0.0395	CbGeAlD
Alendronate—PTPRE—vagina—polycystic ovary syndrome	0.0252	0.0393	CbGeAlD
Alendronate—PTPRS—adipose tissue—polycystic ovary syndrome	0.0247	0.0385	CbGeAlD
Alendronate—PTPN4—female gonad—polycystic ovary syndrome	0.0241	0.0376	CbGeAlD
Alendronate—PTPN4—vagina—polycystic ovary syndrome	0.0239	0.0374	CbGeAlD
Alendronate—PTPRE—endocrine gland—polycystic ovary syndrome	0.0236	0.0368	CbGeAlD
Alendronate—PTPN4—endocrine gland—polycystic ovary syndrome	0.0224	0.035	CbGeAlD
Alendronate—PTPRS—adrenal gland—polycystic ovary syndrome	0.0221	0.0345	CbGeAlD
Alendronate—ATP6V1A—embryo—polycystic ovary syndrome	0.0216	0.0337	CbGeAlD
Alendronate—PTPRS—female gonad—polycystic ovary syndrome	0.0206	0.0322	CbGeAlD
Alendronate—PTPRS—Extracellular matrix organization—FBN3—polycystic ovary syndrome	0.0195	0.0692	CbGpPWpGaD
Alendronate—PTPRS—endocrine gland—polycystic ovary syndrome	0.0192	0.03	CbGeAlD
Alendronate—ATP6V1A—adrenal cortex—polycystic ovary syndrome	0.0177	0.0276	CbGeAlD
Alendronate—PTPRE—IL6-mediated signaling events—CRP—polycystic ovary syndrome	0.0176	0.0627	CbGpPWpGaD
Alendronate—ATP6V1A—endometrium—polycystic ovary syndrome	0.0158	0.0246	CbGeAlD
Alendronate—ATP6V1A—Insulin receptor recycling—INSR—polycystic ovary syndrome	0.015	0.0533	CbGpPWpGaD
Alendronate—Gastrointestinal tract irritation—Metformin—polycystic ovary syndrome	0.0147	0.189	CcSEcCtD
Alendronate—ATP6V1A—uterus—polycystic ovary syndrome	0.0146	0.0227	CbGeAlD
Alendronate—ATP6V1A—pituitary gland—polycystic ovary syndrome	0.0143	0.0223	CbGeAlD
Alendronate—ATP6V1A—adipose tissue—polycystic ovary syndrome	0.0142	0.0222	CbGeAlD
Alendronate—FDPS—adrenal cortex—polycystic ovary syndrome	0.0133	0.0208	CbGeAlD
Alendronate—ATP6V1A—adrenal gland—polycystic ovary syndrome	0.0128	0.0199	CbGeAlD
Alendronate—ATP6V1A—Transferrin endocytosis and recycling—TFRC—polycystic ovary syndrome	0.0127	0.0452	CbGpPWpGaD
Alendronate—ATP6V1A—female gonad—polycystic ovary syndrome	0.0119	0.0186	CbGeAlD
Alendronate—FDPS—endometrium—polycystic ovary syndrome	0.0119	0.0186	CbGeAlD
Alendronate—ATP6V1A—vagina—polycystic ovary syndrome	0.0118	0.0185	CbGeAlD
Alendronate—ATP6V1A—endocrine gland—polycystic ovary syndrome	0.0111	0.0173	CbGeAlD
Alendronate—FDPS—uterus—polycystic ovary syndrome	0.011	0.0171	CbGeAlD
Alendronate—FDPS—pituitary gland—polycystic ovary syndrome	0.0108	0.0168	CbGeAlD
Alendronate—FDPS—adipose tissue—polycystic ovary syndrome	0.0107	0.0167	CbGeAlD
Alendronate—FDPS—adrenal gland—polycystic ovary syndrome	0.00962	0.015	CbGeAlD
Alendronate—ATP6V1A—Iron uptake and transport—TFRC—polycystic ovary syndrome	0.00929	0.033	CbGpPWpGaD
Alendronate—FDPS—female gonad—polycystic ovary syndrome	0.00897	0.014	CbGeAlD
Alendronate—FDPS—vagina—polycystic ovary syndrome	0.00892	0.0139	CbGeAlD
Alendronate—FDPS—endocrine gland—polycystic ovary syndrome	0.00834	0.013	CbGeAlD
Alendronate—Heartburn—Metformin—polycystic ovary syndrome	0.00763	0.0981	CcSEcCtD
Alendronate—ATP6V1A—Signaling by Insulin receptor—PDE3B—polycystic ovary syndrome	0.00746	0.0265	CbGpPWpGaD
Alendronate—PTPRS—ECM proteoglycans—SERPINE1—polycystic ovary syndrome	0.00685	0.0244	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—DMD—polycystic ovary syndrome	0.00678	0.0241	CbGpPWpGaD
Alendronate—ATP6V1A—Insulin receptor recycling—INS—polycystic ovary syndrome	0.00664	0.0236	CbGpPWpGaD
Alendronate—PTPRE—IL6-mediated signaling events—IL6—polycystic ovary syndrome	0.00644	0.0229	CbGpPWpGaD
Alendronate—FDPS—SREBP signalling—RBP4—polycystic ovary syndrome	0.00624	0.0222	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling by Insulin receptor—FGF18—polycystic ovary syndrome	0.00519	0.0185	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling by Insulin receptor—GAB1—polycystic ovary syndrome	0.00474	0.0169	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling by Insulin receptor—INSR—polycystic ovary syndrome	0.00453	0.0161	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.00416	0.0148	CbGpPWpGaD
Alendronate—Cramp muscle—Metformin—polycystic ovary syndrome	0.00343	0.0441	CcSEcCtD
Alendronate—Abdominal distension—Metformin—polycystic ovary syndrome	0.00332	0.0426	CcSEcCtD
Alendronate—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.00316	0.0406	CcSEcCtD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.00296	0.0105	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.00285	0.0101	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.00268	0.00953	CbGpPWpGaD
Alendronate—Oedema peripheral—Metformin—polycystic ovary syndrome	0.0026	0.0334	CcSEcCtD
Alendronate—FDPS—SREBP signalling—PPARG—polycystic ovary syndrome	0.00248	0.00881	CbGpPWpGaD
Alendronate—FDPS—SREBP signalling—INS—polycystic ovary syndrome	0.00243	0.00864	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling by Insulin receptor—IRS2—polycystic ovary syndrome	0.0024	0.00853	CbGpPWpGaD
Alendronate—Erythema—Metformin—polycystic ovary syndrome	0.0023	0.0295	CcSEcCtD
Alendronate—Flatulence—Metformin—polycystic ovary syndrome	0.00226	0.0291	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.00225	0.00801	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.00225	0.00801	CbGpPWpGaD
Alendronate—Dysgeusia—Metformin—polycystic ovary syndrome	0.00225	0.0289	CcSEcCtD
Alendronate—Muscle spasms—Metformin—polycystic ovary syndrome	0.00221	0.0284	CcSEcCtD
Alendronate—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00213	0.0274	CcSEcCtD
Alendronate—ATP6V1A—Signaling by Insulin receptor—IRS1—polycystic ovary syndrome	0.00209	0.00745	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—NMNAT3—polycystic ovary syndrome	0.00207	0.00737	CbGpPWpGaD
Alendronate—Malaise—Metformin—polycystic ovary syndrome	0.00207	0.0266	CcSEcCtD
Alendronate—ATP6V1A—Signaling by Insulin receptor—INS—polycystic ovary syndrome	0.00201	0.00713	CbGpPWpGaD
Alendronate—Myalgia—Metformin—polycystic ovary syndrome	0.00196	0.0251	CcSEcCtD
Alendronate—Chest pain—Metformin—polycystic ovary syndrome	0.00196	0.0251	CcSEcCtD
Alendronate—PTPRS—Extracellular matrix organization—SERPINE1—polycystic ovary syndrome	0.00195	0.00695	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling by Insulin receptor—AKT2—polycystic ovary syndrome	0.00194	0.00689	CbGpPWpGaD
Alendronate—Discomfort—Metformin—polycystic ovary syndrome	0.00193	0.0248	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.00192	0.00681	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.00192	0.00681	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.00189	0.00671	CbGpPWpGaD
Alendronate—Infection—Metformin—polycystic ovary syndrome	0.00186	0.0239	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.00179	0.00637	CbGpPWpGaD
Alendronate—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00171	0.0219	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.00171	0.00607	CbGpPWpGaD
Alendronate—Dyspepsia—Metformin—polycystic ovary syndrome	0.00165	0.0212	CcSEcCtD
Alendronate—Constipation—Metformin—polycystic ovary syndrome	0.0016	0.0206	CcSEcCtD
Alendronate—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00154	0.0198	CcSEcCtD
Alendronate—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00153	0.0197	CcSEcCtD
Alendronate—Urticaria—Metformin—polycystic ovary syndrome	0.00149	0.0191	CcSEcCtD
Alendronate—Abdominal pain—Metformin—polycystic ovary syndrome	0.00148	0.019	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.00145	0.00516	CbGpPWpGaD
Alendronate—FDPS—Metabolism—NMNAT3—polycystic ovary syndrome	0.00139	0.00494	CbGpPWpGaD
Alendronate—Asthenia—Metformin—polycystic ovary syndrome	0.00134	0.0173	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—FLT4—polycystic ovary syndrome	0.00133	0.00472	CbGpPWpGaD
Alendronate—Pruritus—Metformin—polycystic ovary syndrome	0.00133	0.017	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.00132	0.00471	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.00129	0.0046	CbGpPWpGaD
Alendronate—Diarrhoea—Metformin—polycystic ovary syndrome	0.00128	0.0165	CcSEcCtD
Alendronate—FDPS—Metabolism—LPCAT2—polycystic ovary syndrome	0.00127	0.00451	CbGpPWpGaD
Alendronate—FDPS—Metabolism—SUOX—polycystic ovary syndrome	0.00127	0.00451	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.00125	0.00446	CbGpPWpGaD
Alendronate—Dizziness—Metformin—polycystic ovary syndrome	0.00124	0.0159	CcSEcCtD
Alendronate—Vomiting—Metformin—polycystic ovary syndrome	0.00119	0.0153	CcSEcCtD
Alendronate—Rash—Metformin—polycystic ovary syndrome	0.00118	0.0152	CcSEcCtD
Alendronate—Dermatitis—Metformin—polycystic ovary syndrome	0.00118	0.0152	CcSEcCtD
Alendronate—FDPS—Metabolism—ISYNA1—polycystic ovary syndrome	0.00118	0.0042	CbGpPWpGaD
Alendronate—Headache—Metformin—polycystic ovary syndrome	0.00117	0.0151	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—NPB—polycystic ovary syndrome	0.00116	0.00413	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.00115	0.0041	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.00112	0.00398	CbGpPWpGaD
Alendronate—Nausea—Metformin—polycystic ovary syndrome	0.00111	0.0143	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.00108	0.00383	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—RPL37A—polycystic ovary syndrome	0.00107	0.0038	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.00105	0.00373	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.00104	0.0037	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.00102	0.00363	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—HMMR—polycystic ovary syndrome	0.00101	0.0036	CbGpPWpGaD
Alendronate—FDPS—Metabolism—AKR1C2—polycystic ovary syndrome	0.001	0.00357	CbGpPWpGaD
Alendronate—FDPS—Metabolism—TEAD2—polycystic ovary syndrome	0.001	0.00357	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000969	0.00344	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000969	0.00344	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000965	0.00343	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000951	0.00338	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.00095	0.00338	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000906	0.00322	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.00088	0.00313	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling by Insulin receptor—IL6—polycystic ovary syndrome	0.000876	0.00312	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000856	0.00304	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PNPLA2—polycystic ovary syndrome	0.000841	0.00299	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000834	0.00296	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—AKR1C1—polycystic ovary syndrome	0.000834	0.00296	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000798	0.00284	CbGpPWpGaD
Alendronate—FDPS—Metabolism—SRD5A1—polycystic ovary syndrome	0.000797	0.00283	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000778	0.00277	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—FGF18—polycystic ovary syndrome	0.000774	0.00275	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—RBP4—polycystic ovary syndrome	0.000767	0.00273	CbGpPWpGaD
Alendronate—FDPS—Metabolism—STAR—polycystic ovary syndrome	0.000761	0.0027	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000752	0.00267	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000709	0.00252	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—GAB1—polycystic ovary syndrome	0.000707	0.00251	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—NAMPT—polycystic ovary syndrome	0.000688	0.00245	CbGpPWpGaD
Alendronate—FDPS—Metabolism—HMMR—polycystic ovary syndrome	0.000678	0.00241	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000667	0.00237	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000648	0.00231	CbGpPWpGaD
Alendronate—FDPS—Metabolism—HSD3B1—polycystic ovary syndrome	0.000647	0.0023	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—AKR1C3—polycystic ovary syndrome	0.000642	0.00228	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000639	0.00227	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—FST—polycystic ovary syndrome	0.000632	0.00225	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—TNRC6B—polycystic ovary syndrome	0.000632	0.00225	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000624	0.00222	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—LHB—polycystic ovary syndrome	0.000617	0.00219	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000606	0.00215	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000603	0.00214	CbGpPWpGaD
Alendronate—FDPS—Metabolism—LHB—polycystic ovary syndrome	0.00059	0.0021	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000584	0.00208	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—SCT—polycystic ovary syndrome	0.000578	0.00206	CbGpPWpGaD
Alendronate—FDPS—Metabolism—HSD3B2—polycystic ovary syndrome	0.000576	0.00205	CbGpPWpGaD
Alendronate—FDPS—Metabolism—AKR1C1—polycystic ovary syndrome	0.000558	0.00198	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000551	0.00196	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000542	0.00193	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—TCF7L2—polycystic ovary syndrome	0.000541	0.00192	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000537	0.00191	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—SLC2A4—polycystic ovary syndrome	0.000532	0.00189	CbGpPWpGaD
Alendronate—FDPS—Metabolism—SULT2A1—polycystic ovary syndrome	0.000514	0.00183	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PRL—polycystic ovary syndrome	0.000507	0.0018	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000502	0.00178	CbGpPWpGaD
Alendronate—FDPS—Metabolism—RRM2—polycystic ovary syndrome	0.000498	0.00177	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000495	0.00176	CbGpPWpGaD
Alendronate—FDPS—Metabolism—YAP1—polycystic ovary syndrome	0.00048	0.00171	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—INSR—polycystic ovary syndrome	0.000473	0.00168	CbGpPWpGaD
Alendronate—FDPS—Metabolism—NAMPT—polycystic ovary syndrome	0.000461	0.00164	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000458	0.00163	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CYP11A1—polycystic ovary syndrome	0.000455	0.00162	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000452	0.00161	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000449	0.0016	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000442	0.00157	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PGR—polycystic ovary syndrome	0.000438	0.00156	CbGpPWpGaD
Alendronate—FDPS—Metabolism—AKR1C3—polycystic ovary syndrome	0.00043	0.00153	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—NCOR1—polycystic ovary syndrome	0.000425	0.00151	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CYP17A1—polycystic ovary syndrome	0.000423	0.0015	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—NRG1—polycystic ovary syndrome	0.000417	0.00148	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000407	0.00145	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000407	0.00145	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000388	0.00138	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000379	0.00135	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—MTHFR—polycystic ovary syndrome	0.000376	0.00134	CbGpPWpGaD
Alendronate—FDPS—Metabolism—TH—polycystic ovary syndrome	0.000366	0.0013	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000359	0.00127	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—IRS2—polycystic ovary syndrome	0.000357	0.00127	CbGpPWpGaD
Alendronate—FDPS—Metabolism—SLC2A4—polycystic ovary syndrome	0.000356	0.00127	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PRL—polycystic ovary syndrome	0.000355	0.00126	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000337	0.0012	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CYP19A1—polycystic ovary syndrome	0.000335	0.00119	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000313	0.00111	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—IRS1—polycystic ovary syndrome	0.000312	0.00111	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—INS—polycystic ovary syndrome	0.000299	0.00106	CbGpPWpGaD
Alendronate—FDPS—Metabolism—GNAS—polycystic ovary syndrome	0.000299	0.00106	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000298	0.00106	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000292	0.00104	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—AKT2—polycystic ovary syndrome	0.000289	0.00103	CbGpPWpGaD
Alendronate—FDPS—Metabolism—NCOR1—polycystic ovary syndrome	0.000285	0.00101	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—SERPINE1—polycystic ovary syndrome	0.000275	0.000976	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CYP1A1—polycystic ovary syndrome	0.00027	0.00096	CbGpPWpGaD
Alendronate—FDPS—Metabolism—MTHFR—polycystic ovary syndrome	0.000252	0.000895	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—IRS2—polycystic ovary syndrome	0.00025	0.00089	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—LEP—polycystic ovary syndrome	0.000245	0.000871	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000219	0.000777	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—POMC—polycystic ovary syndrome	0.00021	0.000748	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—INS—polycystic ovary syndrome	0.000209	0.000744	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PPARG—polycystic ovary syndrome	0.000204	0.000725	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000202	0.00072	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000202	0.000719	CbGpPWpGaD
Alendronate—FDPS—Metabolism—POMC—polycystic ovary syndrome	0.000201	0.000715	CbGpPWpGaD
Alendronate—FDPS—Metabolism—INS—polycystic ovary syndrome	0.0002	0.000711	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000192	0.000684	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—VEGFA—polycystic ovary syndrome	0.000132	0.00047	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—IL6—polycystic ovary syndrome	0.000131	0.000464	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—IL6—polycystic ovary syndrome	9.14e-05	0.000325	CbGpPWpGaD
